tirzepatide and heart issues UC Irvine researchers project cardiac benefits from weight-loss medication Does Tirzepatide Help Your Heart?

The 3 mg product has potential as a long-term obesity therapy, although current long-term safety and efficacy data are limited

Comparing Oral and Subcutaneous GLP-1 Options Its essential to understand that oral GLP-1 options are not as potent as the subcutaneous injections

According to the FDA, Wegovy is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater

Over time, they help align appetite, diet, and physical activity with your wellness goals, supporting a healthier lifestyle and lasting metabolic health

PMC Full Text Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JHS